Populix, an Indonesia-based market research tech startup, has netted USD 4.3 million in the first close of its Series B round ...

Google Cloud’s latest enhancements to Vertex AI and the Gemini model family offer businesses a comprehensive solution for building, deploying, and managing AI applications with unprecedented ...

The annual licence fee for private electric cars in Hong Kong will be raised gradually in three years to about 70 per cent of that of petrol vehicles under part of the government’s review ...

Hong Kong residents can once again enjoy films at theatres for HK$30 (US$3.90) with the return of the annual Cinema Day event on May 10. The government announced the city’s third consecutive ...

The move comes before President Trump’s planned imposition of new tariffs on small packages sent to the United States from Hong Kong and China. By Alexandra Stevenson Reporting from Hong Kong ...

BOSTON, April 11, 2025--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Paul Negulescu, Ph.D. Senior Vice President, Vertex has been awarded the 2025 Canada Gairdner ...

Hong Kong’s postal service will stop handling packages coming from or going to the United States, in the latest retaliatory move amid an escalating trade war between Washington and Beijing.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

KING OF PRUSSIA, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release first ...

Huaxia Fund is set to launch staking services on its Ether exchange-traded fund (ETF), making it the second in Hong Kong. OSL Digital Services (OSL) will provide custody and staking infrastructure ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbosacral radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...